These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33108015)

  • 1. Topical corticosteroid vehicle composition and implications for clinical practice.
    Oakley R; Arents BWM; Lawton S; Danby S; Surber C
    Clin Exp Dermatol; 2021 Mar; 46(2):259-269. PubMed ID: 33108015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Topical Corticosteroid Prescribing, Counseling, and Communication Among Dermatologists and Pharmacists.
    Millard AN; Stratman EJ
    JAMA Dermatol; 2019 Jul; 155(7):838-843. PubMed ID: 30916731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2012 Dec; 11(12):s5-8. PubMed ID: 23547332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mystical effects of dermatological vehicles.
    Surber C; Smith EW
    Dermatology; 2005; 210(2):157-68. PubMed ID: 15724099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term topical corticosteroid use and risk of skin cancer: a systematic review.
    Ratib S; Burden-Teh E; Leonardi-Bee J; Harwood C; Bath-Hextall F
    JBI Database System Rev Implement Rep; 2018 Jun; 16(6):1387-1397. PubMed ID: 29894408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.
    Mori M; Pimpinelli N; Giannotti B
    Drug Saf; 1994 May; 10(5):406-12. PubMed ID: 8037890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C; Colquitt JL; Kirby J; Davidson P; Payne E
    Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of topical corticosteroid prescribing in the United States, 1989-1991.
    Stern RS
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroids in infants: prescribing pattern and prescribing errors in Bahrain.
    Al Khaja KA; Damanhori AH; Al-Ansari TM; Sequeira RP
    Pharm World Sci; 2007 Aug; 29(4):395-9. PubMed ID: 17295089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergens in corticosteroid vehicles.
    Coloe J; Zirwas MJ
    Dermatitis; 2008; 19(1):38-42. PubMed ID: 18346395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Topical Corticosteroid Foams.
    Payne J; Habet KA; Pona A; Feldman SR
    J Drugs Dermatol; 2019 Aug; 18(8):756-770. PubMed ID: 31424707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The topical corticosteroid classification called into question: towards a new approach.
    Humbert P; Guichard A
    Exp Dermatol; 2015 May; 24(5):393-5. PubMed ID: 25707534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact allergens in topical corticosteroid vehicles: analysis of product composition.
    Dumycz K; Osinka K; Feleszko W
    Contact Dermatitis; 2017 Apr; 76(4):254-255. PubMed ID: 28317192
    [No Abstract]   [Full Text] [Related]  

  • 16. Conventional topical delivery systems.
    Weiss SC
    Dermatol Ther; 2011; 24(5):471-6. PubMed ID: 22353153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence (bioavailability) of generic topical corticosteroids.
    Jackson DB; Thompson C; McCormack JR; Guin JD
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):791-6. PubMed ID: 2715430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis.
    Beattie PE; Lewis-Jones MS
    Clin Exp Dermatol; 2003 Sep; 28(5):549-53. PubMed ID: 12950351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of E
    Rath S; Zvidzayi M; Bon C; Kanfer I
    Basic Clin Pharmacol Toxicol; 2022 Sep; 131(3):165-173. PubMed ID: 35639025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical corticosteroid therapy. Considerations for prescribing and use.
    Nicol NH; Baumeister LL
    Lippincotts Prim Care Pract; 1997; 1(1):62-9. PubMed ID: 9166610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.